Backed by decades of experience and technologies, Creative Biolabs is excited to announce its comprehensive portfolio of liposomal drug delivery solutions to enhance the effectiveness of drugs.
SHIRLEY, NY, February 25, 2025 /24-7PressRelease/ — This capability of the liposomes to encapsulate hydrophilic or lipophilic drugs has made it a wonderful drug delivery carrier. Creative Biolabs, one of the foremost biotechnology companies, maintains keeping up with the rapid advancements in liposome technologies. Guided by a team of highly experienced scientists, the company has launched excellent and customized solutions to meet the changing requirements of pharmaceutical industries. Within the liposome formulations provided by Creative Biolabs, clients can find cationic, long-circulating, and immunoliposomes tailor-made to meet specific therapeutic needs. This unique form of custom-made liposome formulations allows clients to optimize the pharmacokinetic characteristics of their drugs and minimize side effects.
“Liposomes are advanced delivery systems that have a great potential of enhancing the efficacy of active pharmaceutical ingredients (APIs),” says one of the scientists at Creative Biolabs. “Our scientists today provide state-of-the-art liposome-based drug delivery services for pharmaceutical development of all active compounds, including oligonucleotides, small molecules, proteins, and vaccine antigens.”
Some notable benefits of liposomal delivery systems created by Creative Biolabs are that drugs can now be stabilized and protected against harsh degradation. This feature adds considerable benefit when it comes to the management of sensitive molecules such as nucleotides and proteins; it assures the delivery of its active constituents to its target site without impairing its activity.
This company also focuses on liposome characterization. Scientists at this company examine crucial physicochemical properties like particle size, encapsulation efficiency, and zeta potential, which contribute significantly to the safety and efficacy of liposomal products. Through the application of advanced technologies such as dynamic light scattering and electron microscopy, the experienced scientists at Creative Biolabs deliver precise and reliable characterization, which is critical for efficient drug delivery systems.
Apart from this, to assist customers in research and development, Creative Biolabs provides in vitro release kinetics (IVR) analysis. It is necessary to determine the release profile of the encapsulated drug to identify the best formulation and effectiveness. IVR testing foretells drugs’ in vivo performance through the simulation of conditions in the body where liposomes are designed to release specific rates and dosages.
“The scientific research regarding the functions and uses of liposomes is far from complete, and there are further possibilities for their use in the future. For this reason, we will continue prospective research in the field of liposomes, exploring more potential scientific applications,” said the manager at Creative Biolabs.
Learn more, please go to https://www.creative-biolabs.com/lipid-based-delivery/.
About Creative Biolabs
Creative Biolabs is an American biotech company specializing in liposomal drug research and delivery systems. It offers innovative research solutions and high-quality liposome products to global customers. With its tailored liposome development and comprehensive characterization services, Creative Biolabs helps its partners deliver safer and more effective therapies to the market.
—
For the original version of this press release, please visit 24-7PressRelease.com here
